- Home
- SYRS vs EVOK Comparison
SYRS vs EVOK Comparison
Compare SYRS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRS
- EVOK
- Stock Information
- Founded
- SYRS 2011
- EVOK 2007
- Country
- SYRS United States
- EVOK United States
- Employees
- SYRS N/A
- EVOK N/A
- Industry
- SYRS Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- SYRS Health Care
- EVOK Health Care
- Exchange
- SYRS Nasdaq
- EVOK Nasdaq
- Market Cap
- SYRS 7.1M
- EVOK 7.0M
- IPO Year
- SYRS 2016
- EVOK 2013
- Fundamental
- Price
- SYRS $0.20
- EVOK $4.82
- Analyst Decision
- SYRS Hold
- EVOK
- Analyst Count
- SYRS 5
- EVOK 0
- Target Price
- SYRS $3.00
- EVOK N/A
- AVG Volume (30 Days)
- SYRS 2.4M
- EVOK 38.4K
- Earning Date
- SYRS 10-31-2024
- EVOK 11-07-2024
- Dividend Yield
- SYRS N/A
- EVOK N/A
- EPS Growth
- SYRS N/A
- EVOK N/A
- EPS
- SYRS N/A
- EVOK N/A
- Revenue
- SYRS $386,000.00
- EVOK $8,617,036.00
- Revenue This Year
- SYRS N/A
- EVOK $97.35
- Revenue Next Year
- SYRS $1,011.11
- EVOK $99.52
- P/E Ratio
- SYRS N/A
- EVOK N/A
- Revenue Growth
- SYRS N/A
- EVOK 100.35
- 52 Week Low
- SYRS $0.18
- EVOK $3.54
- 52 Week High
- SYRS $8.17
- EVOK $14.04
- Technical
- Relative Strength Index (RSI)
- SYRS 29.55
- EVOK 54.25
- Support Level
- SYRS $0.20
- EVOK $4.80
- Resistance Level
- SYRS $0.22
- EVOK $5.75
- Average True Range (ATR)
- SYRS 0.02
- EVOK 0.38
- MACD
- SYRS 0.06
- EVOK 0.11
- Stochastic Oscillator
- SYRS 25.71
- EVOK 52.61
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.